Genetic suppression features ABHD18 as a Barth syndrome therapeutic target
Genetic suppression features ABHD18 as a Barth syndrome therapeutic target Summary This Nature study uses genome-wide genetic suppression screens (CRISPR and gene-trap) to identify ABHD18 as a modifier of TAFAZZIN…
